{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T15:13:20Z","timestamp":1785683600946,"version":"3.56.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"S3","license":[{"start":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T00:00:00Z","timestamp":1701043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T00:00:00Z","timestamp":1701043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathologie"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s00292-023-01258-6","type":"journal-article","created":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T10:04:08Z","timestamp":1701079448000},"page":"136-139","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Primary cutaneous CD30+ lymphoproliferative disorders with DUSP22 translocation","Prim\u00e4r kutane CD30-positive lymphoproliferative Erkrankungen mit DUSP22-Translokation"],"prefix":"10.1007","volume":"44","author":[{"given":"Santiago","family":"Montes-Moreno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,27]]},"reference":[{"issue":"8","key":"1258_CR1","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1097\/PAS.0b013e318282d01e","volume":"37","author":"LJ Karai","year":"2013","unstructured":"Karai\u00a0LJ, Kadin\u00a0ME, Hsi\u00a0ED et\u00a0al (2013) Chromosomal rearrangements of 6p25.3 define a\u00a0new subtype of lymphomatoid papulosis. Am J Surg Pathol 37(8):1173\u20131181","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"1258_CR2","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/modpathol.2010.225","volume":"24","author":"DA Wada","year":"2011","unstructured":"Wada\u00a0DA, Law\u00a0ME, Hsi\u00a0ED et\u00a0al (2011) Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a\u00a0multicenter study of 204 skin biopsies. Mod Pathol 24(4):596\u2013605","journal-title":"Mod Pathol"},{"issue":"3","key":"1258_CR3","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/jid.2009.314","volume":"130","author":"A Pham-Ledard","year":"2010","unstructured":"Pham-Ledard\u00a0A, Prochazkova-Carlotti\u00a0M, Laharanne\u00a0E et al (2010) IRF4 gene rearrangements define a\u00a0subgroup of CD30-positive cutaneous T\u2011cell lymphoma: a\u00a0study of 54\u00a0cases. J\u00a0Invest Dermatol 130(3):816\u2013825","journal-title":"J Invest Dermatol"},{"issue":"9","key":"1258_CR4","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","volume":"124","author":"ER Parrilla Castellar","year":"2014","unstructured":"Parrilla Castellar\u00a0ER, Jaffe\u00a0ES, Said\u00a0JW et al (2014) ALK-negative anaplastic large cell lymphoma is a\u00a0genetically heterogeneous disease with widely disparate clinical outcomes. Blood 124(9):1473\u20131480","journal-title":"Blood"},{"issue":"3","key":"1258_CR5","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/leu.2008.320","volume":"23","author":"AL Feldman","year":"2009","unstructured":"Feldman\u00a0AL, Law\u00a0M, Remstein\u00a0ED et al (2009) Recurrent translocations involving the IRF4 oncogene locus in peripheral T\u2011cell lymphomas. Leukemia 23(3):574\u2013580","journal-title":"Leukemia"},{"issue":"4","key":"1258_CR6","doi-asserted-by":"publisher","first-page":"E158","DOI":"10.3324\/haematol.2018.205880","volume":"104","author":"A Onaindia","year":"2019","unstructured":"Onaindia\u00a0A, de Villambrosia\u00a0SG, Prieto-Torres\u00a0L et al (2019) DUSP22-rearranged anaplastic lymphomas are characterized by specific morphological features and a\u00a0lack of cytotoxic and JAK\/STAT surrogate markers. Haematologica 104(4):E158\u2013E162","journal-title":"Haematologica"},{"issue":"6","key":"1258_CR7","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/his.12529","volume":"66","author":"A Onaindia","year":"2015","unstructured":"Onaindia\u00a0A, Montes-Moreno\u00a0S, Rodriguez-Pinilla\u00a0SM et al (2015) Primary cutaneous anaplastic large cell lymphomas with 6p25.3 rearrangement exhibit particular histological features. Histopathology 66(6):846\u2013855","journal-title":"Histopathology"},{"issue":"5","key":"1258_CR8","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s00428-019-02713-7","volume":"476","author":"I Oschlies","year":"2020","unstructured":"Oschlies\u00a0I, King\u00a0RL, Dotlic\u00a0S et al (2020) The clinico-pathological spectrum of primary cutaneous lymphoma other than mycosis fungoides\/Sezary syndrome. virchows Arch 476(5):683\u2013699","journal-title":"virchows Arch"},{"issue":"4","key":"1258_CR9","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/PAS.0000000000001614","volume":"45","author":"A Ravindran","year":"2021","unstructured":"Ravindran\u00a0A, Feldman\u00a0AL, Ketterling\u00a0RP et\u00a0al (2021) Striking association of lymphoid enhancing factor (LEF1) overexpression and DUSP22 rearrangements in anaplastic large cell lymphoma. Am J Surg Pathol 45(4):550\u2013557","journal-title":"Am J Surg Pathol"},{"issue":"13","key":"1258_CR10","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1182\/blood-2018-03-838524","volume":"132","author":"RA Luchtel","year":"2018","unstructured":"Luchtel\u00a0RA, Dasari\u00a0S, Oishi\u00a0N et\u00a0al (2018) Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with. Blood 132(13):1386\u20131398","journal-title":"Blood"},{"issue":"26","key":"1258_CR11","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1182\/blood.2019000626","volume":"133","author":"RA Luchtel","year":"2019","unstructured":"Luchtel\u00a0RA, Zimmermann\u00a0MT, Hu\u00a0G et al (2019) Recurrent MSC E116K mutations in ALK-negative anaplastic large cell lymphoma. Blood 133(26):2776\u20132789","journal-title":"Blood"}],"container-title":["Die Pathologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-023-01258-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00292-023-01258-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-023-01258-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T08:05:04Z","timestamp":1703145904000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00292-023-01258-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,27]]},"references-count":11,"journal-issue":{"issue":"S3","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["1258"],"URL":"https:\/\/doi.org\/10.1007\/s00292-023-01258-6","relation":{},"ISSN":["2731-7188","2731-7196"],"issn-type":[{"value":"2731-7188","type":"print"},{"value":"2731-7196","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,27]]},"assertion":[{"value":"19 October 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"S.\u00a0Montes-Moreno declares that he has no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case. Informed consent was obtained from all individual participants from whom identifying information is included in this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The supplement containing this article is not sponsored by industry.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}